Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111722 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marcela Vela-Amieva und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Errores Innatos del Metabolismo y Tamiz, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City C.P. 04530, Mexico. Hauptthemen laut MEDLINE: Exome Sequencing, Metabolism, Inborn Errors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Pediatría, Instituto Nacional de Pediatría, Secretaría de Salud.
Abstract (Originalsprache)
Biochemical phenotyping has been the milestone for diagnosing and managing patients affected by inborn errors of intermediary metabolism (IEiM); however, identifying the genotype responsible for these monogenic disorders greatly contributes to achieving these goals. Herein, whole-exome sequencing (WES) was used to determine the genotypes of 95 unrelated Mexican pediatric patients suspected of having IEiM. They were classified into those bearing specific biochemical abnormalities (Group 1), and those presenting unspecific biochemical profiles (Group 2). The overall concordance between the initial biochemical diagnosis and final genotypic diagnoses was 72.6% (N = 69/95 patients), with the highest concordance achieved in Group 1 (91.3%, N = 63/69), whereas the concordance was limited in Group 2 (23.07%). This finding suggests that previous biochemical phenotyping correlated with the high WES diagnostic success. Concordance was high for urea cycle disorders (94.1%) and organic acid disorders (77.4%). The identified mutational spectrum comprised 83 IEiM-relevant variants (pathogenic, likely pathogenic, and variants of uncertain significance or VUS), including three novel ones, distributed among 29 different genes responsible for amino acid, organic acid, urea cycle, carbohydrate, and lipid disorders. Inconclusive WES results (7.3%, N = 7/95) relied on monoallelic pathogenic genotypes or those involving two VUS for autosomal-recessive IEiMs. A second monogenic disease was observed in 10.5% (N = 10/95) of the patients. According to the WES results, modifications in treatment had to be made in 33.6% (N = 32/95) of patients, mainly attributed to the presence of a second monogenic disease, or to an actionable trait. This study includes the largest cohort of Mexican patients to date with biochemically suspected IEiM who were genetically diagnosed through WES, underscoring its importance in medical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Errores Innatos del Metabolismo y Tamiz, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City C.P. 04530, Mexico.
- Laboratorio de Biología Molecular, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City C.P. 04530, Mexico.
- Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas, UNAM, Mexico City C.P. 04530, Mexico.
- 3billion, Inc., Seoul 03161, Republic of Korea.
ORCID-Profile: Marcela Vela-Amieva, Miguel Angel Alcántara-Ortigoza, Ariadna González-Del Angel, Liliana Fernández-Hernández, Miriam Erandi Reyna-Fabián, Sara Guillén-López, Lizbeth López-Mejía, Leticia Belmont-Martínez, Rosa Itzel Carrillo-Nieto, Isabel Ibarra-González, Seung-Woo Ryu, Hane Lee, Cynthia Fernández-Lainez
Förderung
- Instituto Nacional de Pediatría
- Instituto Nacional de Pediatría, Secretaría de Salud
Zitieren
APA
Vela-Amieva, M., Alcántara-Ortigoza, M. A., González-Del Angel, A., Fernández-Hernández, L., Reyna-Fabián, M. E., Estandía-Ortega, B., Guillén-López, S., López-Mejía, L., Belmont-Martínez, L., Carrillo-Nieto, R. I., Ibarra-González, I., Ryu, S. W., Lee, H., Fernández-Lainez, C., & Rare Diseases Mexican Effort Group (RaDiMEG) (2024). Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111722
Vancouver
Vela-Amieva M, Alcántara-Ortigoza MA, González-Del Angel A, Fernández-Hernández L, Reyna-Fabián ME, Estandía-Ortega B, et al. Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111722
BibTeX
@article{VelaAmieva2024,
author = {Vela-Amieva, Marcela and Alcántara-Ortigoza, Miguel Angel and González-Del Angel, Ariadna and Fernández-Hernández, Liliana and Reyna-Fabián, Miriam Erandi and Estandía-Ortega, Bernardette and Guillén-López, Sara and López-Mejía, Lizbeth and Belmont-Martínez, Leticia and Carrillo-Nieto, Rosa Itzel and Ibarra-González, Isabel and Ryu, Seung-Woo and Lee, Hane and Fernández-Lainez, Cynthia and Rare Diseases Mexican Effort Group (RaDiMEG), Rare Diseases Mexican Effort Group (RaDiMEG)},
title = {Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111722}
}
EUVIMED